CLASS II ONGOING Device recall · Reported 5 Apr 2023 · FDA Enforcement Report

PCRopsis Reagent Rvd with Rvd Enhancer: a), Validation Use Only recalled

Entopsis is recalling PCRopsis Reagent Rvd with Rvd Enhancer: a), Validation Use Only, distributed nationwide in the US. The recall was initiated on 21 Feb 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesa) REF 78336001, Lot Numbers: 18, Exp. 05/2023; 20, Exp. 07/2023; 21, Exp. 07/2023; b) REF 78336025, Lot Numbers: 18, Exp. 05/2023; 20, Exp. 07/2023; 21, Exp. 07/2023; c) REF 78336100, Lot Numbers: 21, Exp. 07/2023
Quantity recalled397 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1299-2023
FDA event ID
91723
Recalling firm
Entopsis, Medley, FL
Classification
Class II
Status
Ongoing
Recall initiated
21 Feb 2023
FDA classified
29 Mar 2023
Reported
5 Apr 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

21 Feb 2023Recall initiated by company
29 Mar 2023Classified by FDA+36 days
5 Apr 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of misleading label statements on the product label.

Product as listed by the FDA

PCRopsis Reagent RVD with RVD Enhancer: a) 1 mL, VALIDATION USE ONLY, REF 78336001; b) 25 mL, REF 78336025; c) 100 mL, REF 78336100; Extraction-free PCR from saliva, urine, &swab specimens in transport medium, nucleic acid extraction from a variety of biological samples

Where it was distributed

Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania

Nationwide

Questions about this recall

Why was it recalled?

Presence of misleading label statements on the product label.

Which lots are affected?

a) REF 78336001, Lot Numbers: 18, Exp. 05/2023; 20, Exp. 07/2023; 21, Exp. 07/2023; b) REF 78336025, Lot Numbers: 18, Exp. 05/2023; 20, Exp. 07/2023; 21, Exp. 07/2023; c) REF 78336100, Lot Numbers: 21, Exp. 07/2023

Where was it sold?

Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

6 other products · FDA event 91723

This product is part of a recall event; the main page for the event is PCRopsis Lysis Beads, IVDD: a) 25 tubes recalled by Entopsis.

More recalls from Entopsis

All 7
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIPCRopsis Reagent Buccal, IVD recalled by EntopsisEntopsisOtherNationwide
DeviceCLASS IIPCRopsis Activator: a) recalled by EntopsisEntopsisOtherNationwide
DeviceCLASS IIPCRopsis Reagent Rvd-rt, IVD: a) recalled by EntopsisEntopsisTemperature AbuseNationwide
DeviceCLASS IIPCRopsis Support: a) recalled by EntopsisEntopsisOtherNationwide
DeviceCLASS IIPCRopsis BCSNano recalled by EntopsisEntopsisOtherNationwide

Other Test Kits & Diagnostics recalls

All 2,656